BioGend Therapeutics Co., Ltd. (TPEX: 6733)
Taiwan
· Delayed Price · Currency is TWD 32.85
-0.15 (-0.45%)
Dec 20, 2024, 1:30 PM CST
BioGend Therapeutics Revenue
BioGend Therapeutics had revenue of 44.25M TWD in the quarter ending September 30, 2024, with 110.16% growth. This brings the company's revenue in the last twelve months to 156.64M, up 92.60% year-over-year. In the year 2023, BioGend Therapeutics had annual revenue of 109.91M with 249.51% growth.
Revenue (ttm)
156.64M
Revenue Growth
+92.60%
P/S Ratio
25.81
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.08B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition